The Prevention of Thromboembolic Complications Associated With Coil Embolization

Muhammad Hassan

Status: Completed

Conditions: Prevention; Clopidogrel; Thromboembolic Stroke; Coil Embolization; Aspirin

Treatments: Drug: Aspir-Low Pill

Study type: Observational

Funder types: Other

Identifiers

NCT05512546

Lahore General Hospital

Details and patient eligibility

About

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.

Enrollment: 200 patients

Sex: All

Ages: 45 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All the patients enrolled in the study underwent MRI and Angiography.
• Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI.

Exclusion criteria

• Patients with any history of sensitivity or reaction to aspirin, or any contraindication for MRI, were excluded from the study.

Trial design

200 participants in 2 patient groups

Aspirin Group

Description:

patients were prescribed 75 mg/day of either aspirin for 6 months

Treatment:

Drug: Aspir-Low Pill

Clopidogrel Group

Description:

75mg/day prescribed for 6 months

Treatment:

Drug: Aspir-Low Pill